Ankyra Therapeutics

Boston, United States · Founded 2019 · $45.0M raised

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$45.0M
Last Round
$45.0M Series BNov 2021
Rounds
1

About

Ankyra Therapeutics is a Boston-based clinical-stage biotechnology company developing cancer immunotherapies built on its Anchored Immunotherapy platform, which localizes potent cytokines within tumors to prime a systemic adaptive immune response while limiting systemic toxicity. Its lead candidate, ANK-101, combines a modified IL-12 cytokine with an aluminum hydroxide scaffold (Alhydrogel) that retains the drug at the injection site after intratumoral administration. The approach aims to create durable anti-tumor immune activation across solid tumors.

Summary

Ankyra Therapeutics is a Biotech company based in Boston, United States, founded in 2019. It has raised $45.0M in total across 1 round, most recently a $45.0M Series B round in Nov 2021.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BNov 2021
$45.0M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ankyra Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ankyra-therapeutics"><img src="https://indexed.vc/api/badge/company/ankyra-therapeutics" alt="Ankyra Therapeutics on Indexed.vc" width="260" height="76" /></a>